The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis
CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission
Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra
GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase
Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines
Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase
Ochre Bio a pioneer in the realm of drug development for chronic liver ailments has forged a partnership with Boehringer Ingelheim a prominent German pharmaceutical company Their joint efforts
Hyundai Bioscience has announced positive results from its preclinical study on triplenegative breast cancer The study investigated a combination therapy of a Niclosamidebased oral anticancer drug
Cognivia an innovative AI company revolutionizing pharmaceutical and biotech clinical research with cuttingedge AIML algorithms proudly announces a significant investment milestone Vesalius Biocapital
DM Biotherapeutics Inc a clinicalstage biotech company announced today that it has initiated dosing the first patient in a phase study of DM DM is a novel monoclonal antibody targeting MICAB
